HHM Wealth Advisors LLC Increases Position in iShares Biotechnology ETF (NASDAQ:IBB)

HHM Wealth Advisors LLC grew its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 200.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 225 shares of the financial services provider’s stock after purchasing an additional 150 shares during the quarter. HHM Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $30,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the company. Huntington National Bank boosted its position in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the period. National Bank of Canada FI boosted its position in shares of iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares during the period. Avior Wealth Management LLC grew its stake in shares of iShares Biotechnology ETF by 438.2% in the third quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after buying an additional 2,629 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the period. Finally, Main Management ETF Advisors LLC lifted its stake in iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $137.85 on Tuesday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The company’s 50 day moving average price is $136.33 and its 200 day moving average price is $141.50.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.